This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reamon-Buettner, S. M. Articles by Borlak, J. Search for Related Content PubMed PubMed Citation Articles by Reamon-Buettner, S. M. Articles by Borlak, J.

(American Journal of Pathology. 2004;164:2117-2125.)
© 2004 American Society for Investigative Pathology

Novel NKX2–5 Mutations in Diseased Heart Tissues of Patients with Cardiac Malformations

Stella Marie Reamon-Buettner^*, Hartmut Hecker, Katharina Spanel-Borowski, Steffen Craatz, Eberhard Kuenzel and Juergen Borlak^*

From the Department of Drug Research and Medical Biotechnology,^*Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover; the Institute of Biometrics,Medical School of Hannover, Hannover; and the Institute of Anatomy,University of Leipzig, Leipzig, Germany

NKX2–5 is a homeodomain-containing transcription factor important in cardiac development. Familial mutations in the NKX2–5 gene are associated with cardiac abnormalities, but mutations are rare in sporadic cases. We studied the pathology and molecular genetics of NKX2–5 in diseased heart tissues of 68 patients with complex congenital heart disease (CHD), particularly atrial (ASD), ventricular (VSD), and atrioventricular septal defects (AVSD). We also studied DNA extracted from 16 normal hearts, as well as lymphocytic DNA from 50 healthy volunteers, 7 families, and 4 unrelated individuals with CHD. Direct sequencing revealed 53 NKX2–5 mutations in the diseased heart tissues, including nonsynonymous substitutions in the homeodomain of NKX2–5. We found common mutations among unrelated patients, but certain mutations were specific to VSDs and AVSDs. Many patients had multiple NKX2–5 mutations, up to 14 nonsynonymous mutations per patient in VSDs. Importantly, these nonsynonymous mutations were mainly absent in normal heart tissues of the same CHD patients, thus indicating somatic origin and mosaicism of mutations. Further, observed mutations were completely absent in normal hearts and lymphocytic DNA of healthy individuals. Our findings provide new insights for somatic NKX2–5 mutations to be of importance in congenital heart disease.

This article has been cited by other articles:

				S. M. Reamon-Buettner, Y. Ciribilli, A. Inga, and J. Borlak A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts Hum. Mol. Genet., May 15, 2008; 17(10): 1397 - 1405. [Abstract] [Full Text] [PDF]

				S M Reamon-Buettner and J Borlak Somatic mutations in cardiac malformations. J. Med. Genet., August 1, 2006; 43(8): e45 - e45. [Full Text] [PDF]

				A. Inga, S. M. Reamon-Buettner, J. Borlak, and M. A. Resnick Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system Hum. Mol. Genet., July 15, 2005; 14(14): 1965 - 1975. [Abstract] [Full Text] [PDF]

				S M Reamon-Buettner and J Borlak GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart J. Med. Genet., May 1, 2005; 42(5): e32 - e32. [Full Text] [PDF]

				C. Mittmann Molecular basis of AV block and cardiac malformations Cardiovasc Res, October 1, 2004; 64(1): 1 - 2. [Full Text] [PDF]